Page 42 - MemoriaBBN-Eng

HORIZONTAL PROGRAMMES

• Functionalized liposomes useful for the delivery of bioactive compounds. PCT/

EP2013/063646, filing date: 06/28/2013.

• Release of substances into senescent cells. PCT/ES2013/070581, filing date:
08/06/2013.

•
Antibodies for the detection and quantification of anticoagulant agents. PCT/
ES2013/070816, filing date: 11/26/2013.

• Cell culture chamber on biomaterials. PCT/ES2013/070819, filing date:

11/26/2013.

• Modified polyarlyetherketone polymer (PAEK) and method for obtaining it. PCT/

ES2013/070928, filing date: 12/26/2013,

• 1,4,5-trisubstituted 1,2,3-triazole mimetic of RGD and/or OGP10-14, process to
obtain it and uses thereof. PCT/ES2013/070927, filing date: 12/26/2013.

International Applications in National / Regional Phases:

•
Methods and reagents for efficient and targeted delivery of therapeutic molecules
to CXCR4 cells.

• Applications filed in 7 countries/regions: Europe (EP12704711.6; 13/08/2013),

USA (13/979560; 12/07/2013), Japan (2013-548853; 12/07/2013,), China

(201280011605.X; 12/07/2013), Australia (2012206533; 9/07/2013), Israel
(227442; 11/07/2013) and India (2225/KOLNP/2013; 10/07/2013)

CIBER-BBN-Industry Forums and Clinical Forums
Other Transfer
Two CIBER-BBN-Industry Forums have been organized to promote collaboration bet-
and Translation
ween research groups and industry. The forums facilitate identification of affinities
Activities
and common interests by means of describing the working subjects and technologies
that the participants use in the morning of the forum conference, as well as during

bilateral conversations taking place in the afternoon.

Two CIBER-Industry Forums were held in 2013:

• “Bone Therapies” (Madrid, 05/30/2013), organized in collaboration with FENIN.
21 companies 14 CIBER-BBN groups, 4 external research groups and institutions

such as CDTI, OEPM and MSSSI participated. 108 bilateral interviews were held.

• “Biomedical Monitoring Systems” (Madrid, 10/3/2013), organized with the co-

llaboration of FENIN. 36 companies (2 international), 15 groups CIBER-BBN, 12 13
external research centres (including the Fraunhofer Institute) and institutions 20
T
such as MSSSI participated in this international forum. 140 bilateral interviews R
PO
were held.
E
L R
A
NU
N
A
Furthermore, research services offered by our equipment platforms were presented /
in these forums.
BN
B
Like the preceding year, meetings or forums aimed at bringing CIBER-BBN investiga- R-
BE
tors to the clinical environment have been organized in 2013 as well. These forums CI

were:
42